Interestingly, studies tested the anticancer activity of synthetic Se-containing compounds through their suppressive EGFR, because activation of EGFR is strongly associated with tumor growth, progression, metastasis, invasion, and poor prognosis [24, 25]. The gene discussed is EGFR; the disease is neoplasm.